메뉴 건너뛰기




Volumn 16, Issue 2, 2015, Pages 346-351

Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma

Author keywords

Gefitinib; Head and neck; Methotrexate; Recurrent; Squamous cell carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; GEFITINIB; METHOTREXATE; ANTINEOPLASTIC AGENT; QUINAZOLINE DERIVATIVE;

EID: 84924598598     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/15384047.2014.961881     Document Type: Article
Times cited : (32)

References (26)
  • 1
    • 0036751172 scopus 로고    scopus 로고
    • Treatment of locally advanced head and neck cancer: Historical and critical review
    • PMID:12410178
    • Al-Sarraf M. Treatment of locally advanced head and neck cancer: historical and critical review. Cancer Control 2002; 9:387-99; PMID:12410178
    • (2002) Cancer Control , vol.9 , pp. 387-399
    • Al-Sarraf, M.1
  • 2
    • 4444346176 scopus 로고    scopus 로고
    • Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9-year, 337-patient, multi-institutional experience
    • PMID:15277256
    • Brockstein B, Haraf DJ, Rademaker AW, Kies MS, Stenson KM, Rosen F, Mittal BB, Pelzer H, Fung BB, Witt ME, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 2004; 15:1179; PMID:15277256; http://dx.doi.org/10.1093/annonc/mdh308
    • (2004) Ann Oncol , vol.15 , pp. 1179
    • Brockstein, B.1    Haraf, D.J.2    Rademaker, A.W.3    Kies, M.S.4    Stenson, K.M.5    Rosen, F.6    Mittal, B.B.7    Pelzer, H.8    Fung, B.B.9    Witt, M.E.10
  • 3
    • 80051966802 scopus 로고    scopus 로고
    • Management of recurrent head and neck cancer: Recent progress and future directions
    • PMID:21861540
    • Brockstein BE. Management of recurrent head and neck cancer: recent progress and future directions. Drugs 2011; 71:1551-9; PMID:21861540; http://dx.doi.org/10.2165/11592540-000000000-00000
    • (2011) Drugs , vol.71 , pp. 1551-1559
    • Brockstein, B.E.1
  • 4
    • 0026569931 scopus 로고
    • A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
    • PMID:1732427
    • Jacobs C, Lyman G, Velez-Garcia E, Sridhar KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH, Schacter L, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 1992; 10:257-63; PMID:1732427
    • (1992) J Clin Oncol , vol.10 , pp. 257-263
    • Jacobs, C.1    Lyman, G.2    Velez-Garcia, E.3    Sridhar, K.S.4    Knight, W.5    Hochster, H.6    Goodnough, L.T.7    Mortimer, J.E.8    Einhorn, L.H.9    Schacter, L.10
  • 5
    • 0026645077 scopus 로고
    • Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: A Southwest Oncology Group Study
    • PMID:1634913
    • Forastiere AA, Mitch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, Kish JA, McClure S, VonFeldt E, Williamson SK, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: A Southwest Oncology Group Study. J Clin Oncol. 1992; 10:1241-51; PMID:1634913
    • (1992) J Clin Oncol. , vol.10 , pp. 1241-1251
    • Forastiere, A.A.1    Mitch, B.2    Schuller, D.E.3    Ensley, J.F.4    Hutchins, L.F.5    Triozzi, P.6    Kish, J.A.7    McClure, S.8    VonFeldt, E.9    Williamson, S.K.10
  • 6
    • 33144461661 scopus 로고    scopus 로고
    • Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An Eastern Cooperative Oncology Group study
    • PMID:16314626
    • Burtness B, Goldwasser MA, Flood W, Mattar B, Forastiere AA. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol. 2005; 23:8646-54; PMID:16314626; http://dx.doi.org/10.1200/JCO.2005.02.4646
    • (2005) J Clin Oncol , vol.23 , pp. 8646-8654
    • Burtness, B.1    Goldwasser, M.A.2    Flood, W.3    Mattar, B.4    Forastiere, A.A.5
  • 7
    • 33748164404 scopus 로고    scopus 로고
    • Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck
    • PMID:16763278
    • Colevas AD. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol. 2006; 24:2644-52; PMID:16763278; http://dx.doi.org/10.1200/JCO.2005.05.3348
    • (2006) J Clin Oncol , vol.24 , pp. 2644-2652
    • Colevas, A.D.1
  • 8
    • 78649356076 scopus 로고    scopus 로고
    • Optimal treatment for recurrent/metastatic head and neck cancer
    • PMID:20943624
    • Vermorken JB, Specenier P. Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol. 2010; 21:252-61; PMID:20943624; http://dx.doi.org/10.1093/annonc/mdq453
    • (2010) Ann Oncol , vol.21 , pp. 252-261
    • Vermorken, J.B.1    Specenier, P.2
  • 9
    • 84857657980 scopus 로고    scopus 로고
    • Current Treatment Options for Metastatic Head and Neck Cancer
    • PMID:22252884
    • Price KA, Cohen EE. Current Treatment Options for Metastatic Head and Neck Cancer. Curr Treat Options Oncol 2012; 13:35-46; PMID:22252884; http://dx.doi.org/10.1007/s11864-011-0176-y
    • (2012) Curr Treat Options Oncol , vol.13 , pp. 35-46
    • Price, K.A.1    Cohen, E.E.2
  • 10
    • 0030481578 scopus 로고    scopus 로고
    • Low dose sequential methotrexate and 5-fluorouracil administration is effective and safe as neo-adjuvant chemotherapy in oral cancer
    • PMID:8986464
    • Asaumi J, Nishijima K. Low dose sequential methotrexate and 5-fluorouracil administration is effective and safe as neo-adjuvant chemotherapy in oral cancer. In Vivo 1996; 10:559-62; PMID:8986464
    • (1996) In Vivo , vol.10 , pp. 559-562
    • Asaumi, J.1    Nishijima, K.2
  • 11
    • 0021041345 scopus 로고
    • Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer
    • PMID:6366132
    • Browman GP, Archibald SD, Young JE, Hryniuk WM, Russell R, Kiehl K, Levine MN. Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer. J Clin Oncol 1983; 1:787-92; PMID:6366132
    • (1983) J Clin Oncol , vol.1 , pp. 787-792
    • Browman, G.P.1    Archibald, S.D.2    Young, J.E.3    Hryniuk, W.M.4    Russell, R.5    Kiehl, K.6    Levine, M.N.7
  • 12
    • 33748188459 scopus 로고    scopus 로고
    • Epidermal growth factor receptor biology in head and neck cancer
    • PMID:16763281
    • Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. U Clin Oncol 2006; 24:2666; PMID:16763281; http://dx.doi.org/10.1200/JCO.2005.04.8306
    • (2006) U Clin Oncol , vol.24 , pp. 2666
    • Kalyankrishna, S.1    Grandis, J.R.2
  • 13
    • 1242338149 scopus 로고    scopus 로고
    • Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy
    • PMID:14967456
    • Ang KK, Andratschke NH, Milas L. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Int J Radiat Oncol Biol Phys 2004; 58:959-65; PMID:14967456; http://dx.doi.org/10.1016/j.ijrobp.2003.07.010
    • (2004) Int J Radiat Oncol Biol Phys , vol.58 , pp. 959-965
    • Ang, K.K.1    Andratschke, N.H.2    Milas, L.3
  • 14
    • 33748653109 scopus 로고    scopus 로고
    • Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas
    • PMID:16943533
    • Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. Clin Oncol 2006; 24:4170-6; PMID:16943533; http://dx.doi.org/10.1200/JCO.2006.07.2587
    • (2006) Clin Oncol , vol.24 , pp. 4170-4176
    • Chung, C.H.1    Ely, K.2    McGavran, L.3    Varella-Garcia, M.4    Parker, J.5    Parker, N.6    Jarrett, C.7    Carter, J.8    Murphy, B.A.9    Netterville, J.10
  • 15
    • 0037674062 scopus 로고    scopus 로고
    • Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
    • PMID:12743152
    • Cohen EE, Rosen F, Stadler WM, Recant W, Stenson K, Huo D, Vokes EE. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2003; 21:1980-7; PMID:12743152; http://dx.doi.org/10.1200/JCO.2003.10.051
    • (2003) J Clin Oncol , vol.21 , pp. 1980-1987
    • Cohen, E.E.1    Rosen, F.2    Stadler, W.M.3    Recant, W.4    Stenson, K.5    Huo, D.6    Vokes, E.E.7
  • 16
    • 28544432807 scopus 로고    scopus 로고
    • Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    • PMID:16322304
    • Cohen EE, Kane MA, List MA, Brockstein BE, Mehrotra B, Huo D, Mauer AM, Pierce C, Dekker A, Vokes EE. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2005; 11:8418-842; PMID:16322304; http://dx.doi.org/10.1158/1078-0432.CCR-05-1247
    • (2005) Clin Cancer Res , vol.11 , pp. 8418-8842
    • Cohen, E.E.1    Kane, M.A.2    List, M.A.3    Brockstein, B.E.4    Mehrotra, B.5    Huo, D.6    Mauer, A.M.7    Pierce, C.8    Dekker, A.9    Vokes, E.E.10
  • 19
    • 0023553115 scopus 로고
    • Comparison of methotrexate and sequential methotrexate-5-fluorouracil for patients with recurrent squamous cell carcinoma of the oral cavity
    • PMID:3435920
    • Airoldi M, Pedani F, Brando V, Gabriele P, Orecchia R. Comparison of methotrexate and sequential methotrexate-5-fluorouracil for patients with recurrent squamous cell carcinoma of the oral cavity. Chemioterapia 1987; 6:390-2; PMID:3435920
    • (1987) Chemioterapia , vol.6 , pp. 390-392
    • Airoldi, M.1    Pedani, F.2    Brando, V.3    Gabriele, P.4    Orecchia, R.5
  • 20
    • 80051784529 scopus 로고    scopus 로고
    • Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent
    • PMID:21741720
    • Tortochaux J, Tao Y, Tournay E, Lapeyre M, Lesaunier F, Bardet E, Janot F, Lusinchi A, Benhamou E, Bontemps P, et al. Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent. Radiother Oncol 2011; 100:70-5; PMID:21741720; http://dx.doi.org/10.1016/j.radonc.2011.06.025
    • (2011) Radiother Oncol , vol.100 , pp. 70-75
    • Tortochaux, J.1    Tao, Y.2    Tournay, E.3    Lapeyre, M.4    Lesaunier, F.5    Bardet, E.6    Janot, F.7    Lusinchi, A.8    Benhamou, E.9    Bontemps, P.10
  • 21
    • 0029060470 scopus 로고
    • Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: A European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study
    • PMID:7602354
    • Schornagel JH, Verweij J, de Mulder PH, Lapeyre M, Lesaunier F, Bardet E, Janot F, Lusinchi A, Benhamou E, Bontemps P, et al. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study. J Clin Oncol 1995; 13:1649-55; PMID:7602354
    • (1995) J Clin Oncol , vol.13 , pp. 1649-1655
    • Schornagel, J.H.1    Verweij, J.2    De Mulder, P.H.3    Lapeyre, M.4    Lesaunier, F.5    Bardet, E.6    Janot, F.7    Lusinchi, A.8    Benhamou, E.9    Bontemps, P.10
  • 22
    • 0020959598 scopus 로고
    • Methotrexate and 5-fluorouracil in sequence in squamous head and neck cancer
    • PMID:6346497
    • Pitman SW, Kowal CD, Bertino JR. Methotrexate and 5-fluorouracil in sequence in squamous head and neck cancer. Semin Oncol 1983; 10:15-9; PMID:6346497
    • (1983) Semin Oncol , vol.10 , pp. 15-19
    • Pitman, S.W.1    Kowal, C.D.2    Bertino, J.R.3
  • 23
    • 0020544962 scopus 로고
    • Sequential methotrexate-5-fluorouracil treatment of squamous cell carcinoma of the head and neck
    • PMID:6603896
    • Ringborg U, Ewert G, Kinnman J, Lundqvist PG, Strander H. Sequential methotrexate-5-fluorouracil treatment of squamous cell carcinoma of the head and neck. Cancer 1983; 52:971-3; PMID:6603896; http://dx.doi.org/10.1002/1097-0142(19830915)52:6<971::AID-CNCR2820520606>3.0.CO;2-B
    • (1983) Cancer , vol.52 , pp. 971-973
    • Ringborg, U.1    Ewert, G.2    Kinnman, J.3    Lundqvist, P.G.4    Strander, H.5
  • 26
    • 27144546959 scopus 로고    scopus 로고
    • Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer
    • PMID:16007067
    • Shiraki M, Odajima T, Ikeda T, Sasaki A, Satoh M, Yamaguchi A, Noguchi M, Nagai I, Hiratsuka H. Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. Mod Pathol 2005; 18:1482-9; PMID:16007067; http://dx.doi.org/10.1038/modpathol.3800455
    • (2005) Mod Pathol , vol.18 , pp. 1482-1489
    • Shiraki, M.1    Odajima, T.2    Ikeda, T.3    Sasaki, A.4    Satoh, M.5    Yamaguchi, A.6    Noguchi, M.7    Nagai, I.8    Hiratsuka, H.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.